Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets?

Abstract

The pathogenesis of systemic lupus erythematosus (SLE) is characterised by the hyper-activation of immunologic pathways related to the antiviral response. Exogenous and endogenous retroviruses, by integrating their DNA templates in the host cell genome, may epigenetically control the transcription of genes involved in the immune response. Furthermore, their nucleic acids or neo-synthesized proteins could stimulate the sensor molecules placed upstream the inflammatory cascade. Exogenous retroviruses, like human immunodeficiency virus, have been associated to SLE-like manifestations or to a fair SLE diagnosis. In addition, there is some evidence confirming a pathogenic role of human endogenous retroviruses in SLE. In line with these data, the use of antiretroviral agents could represent an attractive opportunity in the future therapeutic algorithms of this disease, but studies are still missing.

Keywords:

• Systemic lupus erythematosus
• retroviruses
• human immunodeficiency virus
• human endogenous retroviruses
• antiretroviral therapy

Disclosure of interest

No potential conflict of interest was reported by the author(s).